P-ISSN 2575-3819
E-ISSN 2575-3827
Vol. 8, Issue 1, 2000January 01, 2000 EDT
Patent Fairness Act of 1999: The Implications of Extending Patents for Pipeline Drugs
Patent Fairness Act of 1999: The Implications of Extending Patents for Pipeline Drugs
Shilpa Patel,
Patent Fairness Act of 1999patent life for pharmaceutical drugsDrug Price Competition and Patent Term Restoration Act of 1984patent term restoration for the drug productan abbreviated new drug application (ANDA)short approval time for pipeline drugs assumption
Articles in Vol. 8, Issue 1, 2000
Vol. 8, Issue 1, 2000
- Network Effects in Technology Markets: Applying the Lessons of Intel and Microsoft to Future Clashes Between Antitrust and Intellectual PropertyJohn T. SomaKevin B. DavisUniversity of Denver College of LawUniversity of Denver College of Law
- Phantom Trademarks: Good Law or Chain Rattling? The Negative Effects of Strict Interpretation of the Lanham Act in the International Flavors and Fragrances DecisionJames E. Carlson
- A Satellite Dish or a Birdbath: The Efforts of the 106th Congress to Revise the Satellite Home Viewer ActChad Hunt
- Extrinsic Evidence in Patent Claim Interpretation: Understanding the Post-Markman ConfusionKarl Koster
- Patent Fairness Act of 1999: The Implications of Extending Patents for Pipeline DrugsShilpa Patel
Shilpa Patel, Patent Fairness Act of 1999: The Implications of Extending Patents for Pipeline Drugs, 8 Ga J.L. & Tech. 145 (2000).